Xvivo Perfusion AB
XVIVO.ST
#5053
Rank
$1.30 B
Marketcap
$41.56
Share price
0.00%
Change (1 day)
86.81%
Change (1 year)
Categories

Operating Margin for Xvivo Perfusion AB (XVIVO.ST)

Operating Margin as of November 2024 (TTM): 17.49%

According to Xvivo Perfusion AB's latest financial reports and stock price the company's current Operating Margin is 17.49%. At the end of 2023 the company had an Operating Margin of 15.82%.

Operating Margin history for Xvivo Perfusion AB from 2013 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
202315.82%194.4%
20225.37%108.3%
20212.58%-108.1%
2020-31.84%-1429.09%
20192.40%-74.28%
20189.31%85.41%
20175.02%131.92%
20162.17%-64.79%
20156.15%-30.68%
20148.88%-42.92%
201315.55%

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.